Home › Juvenile Arthritis › California
Juvenile Arthritis clinical trials in California
3 studies for Juvenile Arthritis are looking for participants at sites in California.
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
- Loma Linda University Health, Loma Linda
RecruitingPhase 1
Ages 2 to 17 · All sexes · Updated Sep 28, 2026 · NCT06751238Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis
- University of California San Francisco Pediatric Rheumatology, San Francisco
RecruitingPhase 3
Ages 2 to 21 · All sexes · Updated Sep 25, 2026 · NCT06654882Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Children's Hospital of Los Angeles, Los Angeles
- Mattel Children's Hospital at University of California Los Angeles, Los Angeles
- Stanford University Medical Center, Palo Alto
- and 2 more
RecruitingObservational study
Up to age 21 · All sexes · Updated Aug 27, 2026 · NCT02418442From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.